Kwang-Su Park

11PUBLICATIONS
37CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsNeural engineeringPharmaceutical delivery technologiesProteins and peptidesEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 16, 2026
Discovery of a Potent, Selective, and In Vivo Efficacious Covalent Inhibitor for Lysine Methyltransferase SETD8.

He Chen, Rudra Prasad Dutta, Zhizhong Li

|May 06, 2025
Development of a brain-penetrant G9a methylase inhibitor to target Alzheimer's disease-associated proteopathology.

Ling Xie, Ryan N Sheehy, Adil Muneer

|Apr 26, 2025
PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation.

Endry Wahyu Syahputra, Hyunji Lee, Hyukjun Cho

|Apr 12, 2024
Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader.

Md Kabir, Lihuai Qin, Kaixiu Luo

|Apr 11, 2024
Discovery of the First-in-Class G9a/GLP PROTAC Degrader.

Julia Velez, Yulin Han, Hyerin Yim

|Mar 27, 2024
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.

Yan Xiong, Holger Greschik, Catrine Johansson

Pageof 2

Frequent Collaborators

10 joint publications

Jian Jin

3 joint publications

Jing Liu

2 joint publications

Yongyi Li

2 joint publications

Manfred Jung